Navigation Links
Angiotech announces preliminary third quarter financial results and updates fiscal 2007 outlook
Date:10/19/2007

s were $132.7 million.

- Angiotech expects to post a net loss on a GAAP and adjusted basis for

the third quarter, pending finalization of certain tax items.

With the third quarter results as reported, we are updating our full year 2007 outlook as follows:

- We are updating our full year 2007 expected royalty revenue range

to $118 million to $120 million, based on third quarter paclitaxel-

eluting stent sales of $448 million announced by BSC in its third

quarter earnings release earlier today and from which we will derive

and record royalty revenue in our fourth quarter of 2007. BSC

announced on October 16 that it plans to present a broad range of

clinical trial data reinforcing the safety and efficacy of TAXUS(R)

coronary stent systems at the upcoming Transcatheter Cardiovascular

Therapeutics (TCT 2007) scientific symposium, which runs from

October 20 to 25 in Washington, DC.

- We are revising our 2007 medical product sales outlook to a range

of $171 million to $173 million, from our previous range of

$190 million to $210 million. Our previous range included expected

revenue of $180 million to $190 million from medical products

obtained in the acquisition of American Medical Instruments, Inc.

(AMI) and $10 million to $30 million from new product lines. We

expect fourth quarter net medical product sales to be between

$42 million and $44 million.

- Our full year 2007 outlook for revenue derived from sales of medical

products obtained from AMI is modestly lower as compared to our

original expectations as a result of our decision to de-emphasize or

discontinue certain product lines that were generating limited or

negative contribution margins in the second half of 2007. In

addition, our previously announced decisi
'/>"/>

SOURCE Angiotech Pharmaceuticals, Inc.
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11

Related biology technology :

1. Speaker announces business members of IT Task Force
2. Doyle announces technology tax credits for Berbee
3. Doyle announces new energy, global warming policies
4. Doyle announces $80M renewable energy strategy
5. GE announces first installation of Discovery VCT
6. UWM announces winners of RGI awards
7. Third Wave announces two senior management appointments
8. Mirus announces new method for making antibodies
9. Merge announces sofware updates, upcoming acquisition
10. Small Tree announces ethernet solution for Apple Xserv G5
11. TEKLYNX International announces new RFID software
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/21/2014)... Aug. 21, 2014  Decision Resources Group finds ... and Mexico ... several newly approved agents, the anticipated label extension ... the launch of emerging biologics will substantially increase ... the emerging IL-5 inhibitors will introduce a new dynamic ...
(Date:8/21/2014)... Calif. , Aug. 21, 2014  Four-dimensional ... and behaviors based on external stimuli such as ... to have a disruptive effect in multiple industries.  ... the business landscape by printing objects ranging from ... and automotive sectors. Logo - ...
(Date:8/21/2014)... SoundConnect , a unified communication ... of the nation’s Fastest Growing Private Companies by ... consecutive year. Inc. magazine today ranked SoundConnect NO. ... exclusive ranking of the nation's fastest-growing private companies. ... the most important segment of the economy—America’s independent ...
(Date:8/20/2014)... it that American Indians largely were wiped out by ... tuberculosis brought to the New World by European explorers., ... people lived in the Americas shortly before Europeans arrived, ... European diseases., But new research led by anthropological geneticists ... of the University of Tubingen in Germany indicates the ...
Breaking Biology Technology:Asthma Agents Currently Face a Suboptimal Coverage Environment in Brazil and Mexico, and as the Treatment Armamentarium Expands, Competitiveness Will Further Intensify 2Asthma Agents Currently Face a Suboptimal Coverage Environment in Brazil and Mexico, and as the Treatment Armamentarium Expands, Competitiveness Will Further Intensify 3Frost & Sullivan: 4-D Printing to Usher in Age of Low-Labor, Fast-Paced Product Manufacturing 2Frost & Sullivan: 4-D Printing to Usher in Age of Low-Labor, Fast-Paced Product Manufacturing 3Frost & Sullivan: 4-D Printing to Usher in Age of Low-Labor, Fast-Paced Product Manufacturing 4SoundConnect Returns on Inc. 5000 List of Fastest Growing Companies 2SoundConnect Returns on Inc. 5000 List of Fastest Growing Companies 3Unusual discovery leads to fascinating tuberculosis theory 2Unusual discovery leads to fascinating tuberculosis theory 3
... 20 /PRNewswire/ - ImmunoVaccine Technologies Inc. (IVT), a ... with the National Research Council Institute for Biodiagnostics ... MRI technology to track the effect of IVT,s ... research has the potential to deliver extremely sensitive ...
... Carolina And ChinaRESEARCH TRIANGLE PARK, N.C., May 20 ... Sciences has signed an agreement with China Medical ... for International Drug Development. Building on strengths of ... and education, the Institute will help to produce ...
... /PRNewswire-FirstCall/ - Oncothyreon Inc. (Nasdaq: ONTY ) ... from several investors to purchase approximately 3.88 million shares ... 2.91 million shares of its common stock for gross ... to purchase the shares and warrants for $2.85 per ...
Cached Biology Technology:ImmunoVaccine Technologies Collaborates with NRC Institute for Biodiagnostics Atlantic to measure effectiveness of DepoVax(TM) with novel MRI Imagin 2The Hamner Institutes Announce Partnership With China Medical City 2The Hamner Institutes Announce Partnership With China Medical City 3Oncothyreon announces commitments to purchase $11.1 million of company securities in a registered direct financing 2
(Date:8/21/2014)... pancreas digesting itself resulting in severe abdominal pain, vomiting ... 20,000 patients are diagnosed with the disease resulting in ... is restricted to intravenous fluid and nutritional support. ... Sciences, who led the research, said "The major causes ... and excessive alcohol intake combined with a high fat ...
(Date:8/20/2014)... Huntsman Cancer Institute (HCI) at the University of Utah ... that encodes BCR-ABL, the unregulated enzyme driving the blood ... Cancer Society, nearly 6,000 new cases of CML will ... called tyrosine kinase inhibitors (TKIs), target BCR-ABL and are ... CML but control it in a way that allows ...
(Date:8/20/2014)... from the University of Tbingen, Arizona State University, the ... Public Health Institute (Swiss TPH) isolated Mycobacterium pinnipedii ... least 1000 years old. The pathogen is a relative ... occasionally causes disease in humans today. These researchers assume ... Peruvian coast. "The link to sea lions was unexpected" ...
Breaking Biology News(10 mins):Insulin offers new hope for the treatment of acute pancreatitis 2Blueprint for next generation of chronic myeloid leukemia treatment 2
... have identified some two million species, where can you ... that unites them all? A vastly improved database gives ... evolutionary relationships among living things. TreeBASE ... study evolutionary trees was first developed in the ...
... enormous range of man-made chemicals, from food, water, medicines, cosmetics, ... of the EU, researchers at the University of Gothenburg, Sweden, ... proposed a number of measures that need to be implemented ... In 2005 an American study showed that newborn babies have ...
... of the ten most important agricultural crops worldwide. In spring, ... visible: this year winter rapeseed is being cultivated on 1.46 ... rapeseed oil can be expected. Beekeepers set up their beehives ... bees can gather nectar This ensures that the rapeseed flowers ...
Cached Biology News:Database gives access to the latest findings about the tree of life 2Database gives access to the latest findings about the tree of life 3Chemical cocktail affects humans and the environment 2Plant hormone regulates nectar production 2Plant hormone regulates nectar production 3
Experion StdSens chips are the microfluidic chips used to perform standard-sensitivity RNA analysis (nanogram levels) with the Experion automated electrophoresis system. Each chip has the capacity to...
... system, 100-120 and 220-240 V, is a ... of gel-based electrophoresis, including some data analysis, ... used for protein analysis (it does not ... analysis). The system includes the electrophoresis station, ...
... preactivated with carbonyl diimidazole chemistry that covalently ... PS10 array contains the same binding chemistry ... an updated hydrophobic barrier coating. These arrays ... diameter spots spatially compatible with one column ...
... Activator of Caspase/DIABLO Liquid. In 100 ... FREEZE/THAW CYCLES. Amino acid residues 56 - 239 ... ® sequence was expressed in and purified ... along with cytochrome c during apoptosis ...
Biology Products: